4//SEC Filing
Lewis Hayley 4
Accession 0001587221-18-000011
CIK 0001587221other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 6:06 PM ET
Size
6.5 KB
Accession
0001587221-18-000011
Insider Transaction Report
Form 4
Lewis Hayley
VP, Reg Affairs & Quality
Transactions
- Award
Employee Stock Option (right to buy)
2017-05-31+180,000→ 180,000 totalExercise: $0.57Exp: 2026-11-02→ Common Stock (180,000 underlying)
Footnotes (4)
- [F1]As a result of a 1-for-20 reverse stock split of the common stock of the Company, which became effective at 5:00 p.m. Eastern Time on January 25, 2018 (the "Reverse Split"), the exercise price has increased from $0.575 per share to $11.50 per share.
- [F2]The option grant was approved by the compensation committee of the Company's board of directors on November 2, 2016, subject to stockholder approval of an amendment to the stock option plan under which the option was granted. The Company's stockholders approved the plan amendment on May 31, 2017.
- [F3]As a result of the Reverse Split, the number of shares of the Company's common stock underlying the stock option has decreased from 180,000 shares to 9,000 shares.
- [F4]25% of the total number of shares underlying the stock option vested on November 2, 2017, and the remaining underlying shares vested or vest in equal monthly installments over the following three-year period, so that all shares shall have vested on November 2, 2020.
Documents
Issuer
Zosano Pharma Corp
CIK 0001587221
Entity typeother
Related Parties
1- filerCIK 0001631295
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 6:06 PM ET
- Size
- 6.5 KB